ATE488767T1 - Verfahren zum nachweis der aktivierung von t- zellen durch mhc-bindende peptide - Google Patents

Verfahren zum nachweis der aktivierung von t- zellen durch mhc-bindende peptide

Info

Publication number
ATE488767T1
ATE488767T1 AT04779108T AT04779108T ATE488767T1 AT E488767 T1 ATE488767 T1 AT E488767T1 AT 04779108 T AT04779108 T AT 04779108T AT 04779108 T AT04779108 T AT 04779108T AT E488767 T1 ATE488767 T1 AT E488767T1
Authority
AT
Austria
Prior art keywords
mhc
detecting
cell activation
methods
binding peptides
Prior art date
Application number
AT04779108T
Other languages
English (en)
Inventor
Jennie Chyan Chuu Chang
Suha Kasey
Veronique Trigueros Crebassa
Felix A Montero-Julian
Original Assignee
Beckman Coulter Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beckman Coulter Inc filed Critical Beckman Coulter Inc
Application granted granted Critical
Publication of ATE488767T1 publication Critical patent/ATE488767T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT04779108T 2003-07-22 2004-07-22 Verfahren zum nachweis der aktivierung von t- zellen durch mhc-bindende peptide ATE488767T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48935903P 2003-07-22 2003-07-22
PCT/US2004/023898 WO2005010026A2 (en) 2003-07-22 2004-07-22 Methods for detecting activation of t-cells by mhc binding peptides

Publications (1)

Publication Number Publication Date
ATE488767T1 true ATE488767T1 (de) 2010-12-15

Family

ID=34102856

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04779108T ATE488767T1 (de) 2003-07-22 2004-07-22 Verfahren zum nachweis der aktivierung von t- zellen durch mhc-bindende peptide

Country Status (4)

Country Link
EP (1) EP1648919B1 (de)
AT (1) ATE488767T1 (de)
DE (1) DE602004030125D1 (de)
WO (1) WO2005010026A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040072262A1 (en) 2002-10-11 2004-04-15 Montero-Julian Felix A. Methods and systems for detecting MHC class I binding peptides
WO2008057366A2 (en) 2006-11-01 2008-05-15 Beckman Coulter, Inc. Binding surfaces for affinity assays
FR2992427A1 (fr) * 2012-06-20 2013-12-27 Assist Publ Hopitaux De Paris Methode de pronostic d'un lymphome et kit pour sa mise en oeuvre
EP3182125A1 (de) * 2015-12-16 2017-06-21 Ab Tcer T-zellreaktivitätsplattform
DK3391047T3 (da) * 2015-12-16 2020-11-16 Tcer Ab T-cellereaktivitetsplatform
EP3455630A4 (de) * 2016-05-13 2020-01-08 MBL International Corp. Peptidaustauschsystem und -verfahren
US11583575B2 (en) 2016-09-06 2023-02-21 Roche Sequencing Solutions, Inc. MHC-bound peptide arrays and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635363A (en) 1995-02-28 1997-06-03 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
JP2004501364A (ja) * 2000-05-25 2004-01-15 スノル・モレキュラー・コーポレーション Ｔ−細胞レセプター相互作用のモジュレーション
US7094555B2 (en) * 2001-04-05 2006-08-22 Benaroya Research Institute At Virginia Mason Methods of MHC class II epitope mapping, detection of autoimmune T cells and antigens, and autoimmune treatment
EP1412535A4 (de) * 2001-07-02 2007-08-22 Univ Leland Stanford Junior Mikroarrays zur phänotypisierung und manipulation von zellen
US20040248205A1 (en) * 2003-04-16 2004-12-09 Stern Lawrence J. Major histocompatibility complex (MHC)-peptide arrays

Also Published As

Publication number Publication date
EP1648919B1 (de) 2010-11-17
DE602004030125D1 (de) 2010-12-30
EP1648919A4 (de) 2007-08-01
WO2005010026A2 (en) 2005-02-03
WO2005010026A3 (en) 2005-06-02
EP1648919A2 (de) 2006-04-26

Similar Documents

Publication Publication Date Title
WO2004034033A3 (en) Methods and systems for detecting mhc class i and class ii binding peptides
DE50301487D1 (de) Reaktionsgefäss zur durchführung von array-verfahren
DK1786927T3 (da) Indretning og fremgangsmåde til påvisning af ladede makromolekyler
ATE477338T1 (de) Vorrichtung und verfahren zum nachweis von molekularen wechselwirkungen
BRPI0515079A (pt) marcadores imobilizados e métodos de detecção de prions conformacionalmente alterados
BRPI0519119A2 (pt) sistema colorimÉtrico e mÉtodo para detectar um analito
WO2006051088A3 (de) Vorrichtungen für die durchführung und analyse von mikroarray-experimenten
DE102005052713A1 (de) Vorrichtung und Verfahren zum Nachweis von molekularen Wechselwirkungen
DK1869475T3 (da) In vitro metode til samtidig detektering og identifikation af antibiotika i forskellige klasser og et tilsvarende diagnosekit
DE60030744D1 (de) Verfahren zum identifizieren von inhibitoren der methioninaminopeptidasen
WO2003100413A3 (en) Surface acoustic wave sensors and methods for detecting target analytes
ATE488767T1 (de) Verfahren zum nachweis der aktivierung von t- zellen durch mhc-bindende peptide
ATE466283T1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
DE502005004900D1 (de) Trägerplatte zur durchführung funktioneller tests an biologischen zellen sowie verfahren zur beschichtung der trägerplatte
DE60317315D1 (de) Nachweis von dna-bindungsproteinen
ATE529533T1 (de) Verfahren zum nachweis von analyten in einer probe
DE60311973D1 (de) Substrat und verfahren zum messen elektrophysiologischer eigenschaften von zellmembranen
DE60306865D1 (de) Detektion von Vancomycin-resistenten Enterococcus-Subspezies
DK1664747T3 (da) Fremgangsmåde og indretning til påvisning af meget små partikelmængder
DE50207025D1 (de) Verfahren zum Nachweis und zur Isolierung von T-Lymphozyten, die ein definiertes Antigen erkennen
ATE533053T1 (de) Nicht-elispot-test
DK1360491T3 (da) Biokemisk fremgangsmåde og apparat til detektion af proteinegenskaber
DE50210523D1 (de) Verfahren zur identifizierung von zielepitopen der t-zell-vermittelten immunantwort und zum nachweis epitop-spezifischer t-zellen
DE50208262D1 (de) Verfahren zur bestimmung von flüchtigen substanzen in lösung
ATE528640T1 (de) Detektionssysteme und -verfahren für flüssigkeitsgekoppelte defekte

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties